Publication:
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers

dc.contributor.authorGalán Burgos, Miguel
dc.contributor.authorVigon-Hernandez, Lorena
dc.contributor.authorFuertes, Daniel
dc.contributor.authorMurciano-Antón, María Aranzazu
dc.contributor.authorCasado-Fernández, Guiomar
dc.contributor.authorDomínguez-Mateos, Susana
dc.contributor.authorMateos, Elena
dc.contributor.authorRamos-Martín, Fernando
dc.contributor.authorPlanelles, Vicente
dc.contributor.authorTorres, Montserrat
dc.contributor.authorRodriguez Mora, Sara
dc.contributor.authorLopez-Huertas, Maria Rosa
dc.contributor.authorCoiras, Mayte
dc.contributor.authorMultidisciplinary Group of Study of COVID-19 (MGS-COVID)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderNational Institutes of Health (Estados Unidos)
dc.contributor.funderChiesi Foundation
dc.contributor.funderRed de Investigación Cooperativa en Investigación en Sida (España)es_ES
dc.date.accessioned2022-08-05T11:23:32Z
dc.date.available2022-08-05T11:23:32Z
dc.date.issued2022-03-25
dc.description.abstractLong-COVID is a new emerging syndrome worldwide that is characterized by the persistence of unresolved signs and symptoms of COVID-19 more than 4 weeks after the infection and even after more than 12 weeks. The underlying mechanisms for Long-COVID are still undefined, but a sustained inflammatory response caused by the persistence of SARS-CoV-2 in organ and tissue sanctuaries or resemblance with an autoimmune disease are within the most considered hypotheses. In this study, we analyzed the usefulness of several demographic, clinical, and immunological parameters as diagnostic biomarkers of Long-COVID in one cohort of Spanish individuals who presented signs and symptoms of this syndrome after 49 weeks post-infection, in comparison with individuals who recovered completely in the first 12 weeks after the infection. We determined that individuals with Long-COVID showed significantly increased levels of functional memory cells with high antiviral cytotoxic activity such as CD8+ TEMRA cells, CD8±TCRγδ+ cells, and NK cells with CD56+CD57+NKG2C+ phenotype. The persistence of these long-lasting cytotoxic populations was supported by enhanced levels of CD4+ Tregs and the expression of the exhaustion marker PD-1 on the surface of CD3+ T lymphocytes. With the use of these immune parameters and significant clinical features such as lethargy, pleuritic chest pain, and dermatological injuries, as well as demographic factors such as female gender and O+ blood type, a Random Forest algorithm predicted the assignment of the participants in the Long-COVID group with 100% accuracy. The definition of the most accurate diagnostic biomarkers could be helpful to detect the development of Long-COVID and to improve the clinical management of these patients.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by the Coordinated Research Activities at the National Center of Microbiology (CNM, Instituto de Salud Carlos III) (COV20_00679) to promote an integrated response against SARS-CoV-2 in Spain (Spanish Ministry of Science and Innovation), which is coordinated by Dr Inmaculada Casas (WHO National Influenza Center of the CNM); a generous donation provided by Chiesi España, S.A.U. (Barcelona, Spain); the Spanish Ministry of Science and Innovation (PID2019-110275RB-I00); and the Spanish AIDS Research Network RD16CIII/0002/0001 that is included in Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2016-2020, Instituto de Salud Carlos III, European Region Development Fund (ERDF). The work of ML-H and SR-M is financed by NIH grant R01AI143567. The work of MT is supported by Instituto de Salud Carlos III (COV20_00679). The work of LV is supported by a pre-doctoral grant from Instituto de Salud Carlos III (FIS PI16CIII/00034-ISCIII-FEDER). The work of FR-M is financed by the Spanish Ministry of Science and Innovation (PID2019-110275RB-I00).es_ES
dc.format.page848886es_ES
dc.format.volume13es_ES
dc.identifier.citationFront Immunol. 2022 Mar 25;13:848886.es_ES
dc.identifier.doi10.3389/fimmu.2022.848886es_ES
dc.identifier.e-issn1664-3224es_ES
dc.identifier.journalFrontiers in Immunologyes_ES
dc.identifier.pubmedID35401523es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14869
dc.language.isoenges_ES
dc.publisherFrontiers Media
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-110275RB-I00es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/COV20_00679es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0001es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI16CIII/00034-ISCIII-FEDERes_ES
dc.relation.publisherversionhttps://doi.org/10.3389/fimmu.2022.848886es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCD8+ T cellses_ES
dc.subjectLong-COVIDes_ES
dc.subjectNK cellses_ES
dc.subjectRandom Forest algorithmes_ES
dc.subjectCytotoxic immune responsees_ES
dc.subjectImmune exhaustiones_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshBiomarkerses_ES
dc.subject.meshCD8-Positive T-Lymphocyteses_ES
dc.subject.meshFemalees_ES
dc.subject.meshHumanses_ES
dc.subject.meshImmunityes_ES
dc.subject.meshSARS-CoV-2es_ES
dc.titlePersistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkerses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione0a53c78-c7cd-41af-8fa1-6d9f8ef8da14
relation.isAuthorOfPublicationa78af867-a6b0-4c76-a129-d8cfa3e8c85e
relation.isAuthorOfPublicationdda259fe-5ac5-4b19-9249-14c375ec516b
relation.isAuthorOfPublication70d4b634-f13f-4b35-a47e-5a337f5acbfc
relation.isAuthorOfPublication5788952b-921a-48da-a0f1-565e8610b2e8
relation.isAuthorOfPublicationf044fea9-eb43-475b-8602-1339d49f31f4
relation.isAuthorOfPublicationc5118ef8-1e9b-46a4-942e-1c8e2b363f57
relation.isAuthorOfPublicationcd13d2cc-b148-4e72-94f3-02e58c5e1abd
relation.isAuthorOfPublicationf729e106-ee5d-450a-b046-63b14e24c1a3
relation.isAuthorOfPublication.latestForDiscoverye0a53c78-c7cd-41af-8fa1-6d9f8ef8da14
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicationd863b318-3e6b-4cfc-81bb-a6d112b1f86e
relation.isFunderOfPublication941a3113-c3cd-4e37-9d61-b8415006c2ac
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Original bundle

Now showing 1 - 5 of 7
Loading...
Thumbnail Image
Name:
PersistentOveractiveCytotoxicImmune_2022.pdf
Size:
2.47 MB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
PersistentOveractiveCytotoxicImmunePresentation1_2022.pdf
Size:
331.15 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Information
Loading...
Thumbnail Image
Name:
PersistentOveractiveCytotoxicImmunePresentation2_2022.pdf
Size:
239.52 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Information
Loading...
Thumbnail Image
Name:
PersistentOveractiveCytotoxicImmunePresentation3_2022.pdf
Size:
138.08 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Information
Loading...
Thumbnail Image
Name:
PersistentOveractiveCytotoxicImmunePresentation4_2022.pdf
Size:
169.99 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Information